Document is current
Any future updates will be listed below
-
Authors
Brinch, Maja L.
Palladino, Andrea
Geurtsen, Jeroen
Van Effelterre, Thierry
Argante, Lorenzo
McConnell, Michael J.
Christiansen, Lene
Pihl, Michelle A.
Lund, Natasja K.
Hald, Tine
-
Funding
Funding for this research was provided by:
Innovative Medicines Initiative (No 101034420)
- License Information
-
More Information
Article History
Received: 14 February 2025
Accepted: 12 May 2025
First Online: 28 May 2025
Declarations
:
: AP and LA are employees of GSK. JG is currently an employee of Sanofi. At the moment this work was conducted, JG was an employee of Janssen Vaccines & Prevention B.V. and a holder of Johnson & Johnson stock options. TE is an employee of Johnson & Johnson and is a Johnson & Johnson stockholder. MJM is a confounder, stockholder, and has received financial support from the biotechnology company Vaxdyn. Vaxdyn played no role in this study.
: Not applicable.
